Available courses

HTA in Action short course: Orientation Module
Varsha Bangalee

HTA in Action short course: Orientation Module

This is for the purpose of introducing the online system to participants in the online course. You will be introduced to how the webinar option works, what to expect from quizzes, where announcements and discussions will be available, how the content will be posted and how to keep track of your grades.

HTA 101: Intervention Research and Clinical Trials
Varsha BangaleeDanie van Zyl

HTA 101: Intervention Research and Clinical Trials

Intervention research is research undertaken to develop new or improved healthcare interventions and to evaluate the effectiveness of pharmacologic interventions. This is considered to be the most reliable evidence in healthcare research. In a clinical trial setting, the researcher aims to explore whether a medical strategy, a treatment or a device is safe and effective for humans. Clinical trials produce the best data available for healthcare decision making by utilising stringent scientific standards and protocols in the design and development of intervention research.


HTA102: Health Economic and HTA Research
Varsha BangaleeMark BrandJacqui Miot

HTA102: Health Economic and HTA Research

Health economics and Health Technology Assessment covers a wide spectrum of activities related to the cost-effectiveness and affordability and access of medicines. The tools that can be used in health economics and HTA may differ depending on the perspective, i.e. public vs private healthcare, macro vs micro setting, primary vs tertiary healthcare etc. This module takes a micro-level view of the health economics of a specific healthcare intervention (e.g. a new high cost medicine) rather than that of a healthcare programme (e.g. rolling out a vaccination programme) or healthcare system. However, this module does incorporate all the fundamental principles of health economics so that you will be able to use these in many different settings.


HTA103: Evidence Based Decision Making in Healthcare
Varsha BangaleeManie de KlerkEdina Sinanovic

HTA103: Evidence Based Decision Making in Healthcare

  • Understand critical appraisal
  • Learn about evaluating Harm
  • Learn where Guidelines fit in
  • Check list for Economic Evaluations
  • Practical examples in Health Economics
We aim to assist the phrasing of focused and specific clinical questions requiring decision making; search medical literature and apply validity criteria to therapeutic, pharmacoeconomic and meta-analytic research.

DMA110: Demystifying Market Access in the South African Healthcare Environment
Mark Brand

DMA110: Demystifying Market Access in the South African Healthcare Environment

Medical device registration e.g. FDA and CE, which are critical quality, safety and efficacy indicators, are merely authorizations to sell a technology, and the absolute minimum requirement for market access, but are not a guarantee for adoption and/or reimbursement; policy makers demand more!

Introducing new technologies to the South Africa Healthcare market is a daunting task, given the potential roadblocks presented by payers and policy makers to manage utilization and health care costs. Although it has a market access focus, this workshop is not exclusively for market access personnel, and every level of business decision-maker will benefit by attending.